AIMS: Atrial fibrillation (AF), typical atrial flutter (AFL), and other atrial tachycardias (ATs) are common in patients with pulmonary hypertension. Frequently, several supraventricular arrhythmias are successively observed in individual patients. We investigated the hypothesis of whether more extensive radiofrequency catheter ablation of the bi-atrial arrhythmogenic substrate instead of clinical arrhythmia ablation alone results in superior clinical outcomes in patients with pulmonary arterial hypertension (PH) and supraventricular arrhythmias. METHODS AND RESULTS: Patients with combined post- and pre-capillary or isolated pre-capillary PH and supraventricular arrhythmia indicated to catheter ablation were enrolled in three centres and randomized 1:1 into two parallel treatment arms. Patients underwent either clinical arrhythmia ablation only (Limited ablation group) or clinical arrhythmia plus substrate-based ablation (Extended ablation group). The primary endpoint was arrhythmia recurrence >30 s without antiarrhythmic drugs after the 3-month blanking period. A total of 77 patients (mean age 67 ± 10 years; 41 males) were enrolled. The presumable clinical arrhythmia was AF in 38 and AT in 36 patients, including typical AFL in 23 patients. During the median follow-up period of 13 (interquartile range: 12; 19) months, the primary endpoint occurred in 15 patients (42%) vs. 17 patients (45%) in the Extended vs. Limited ablation group (hazard ratio: 0.97, 95% confidence interval: 0.49-2.0). There was no excess of procedural complications and clinical follow-up events including an all-cause death in the Extended ablation group. CONCLUSION: Extensive ablation, compared with a limited approach, was not beneficial in terms of arrhythmia recurrence in patients with AF/AT and PH. CLINICAL TRIALS REGISTRATION: ClinicalTrials.gov; NCT04053361.

1st Department of Internal Medicine Cardiology Olomouc University Hospital Olomouc Czech Republic

2nd Department of Medicine Department of Cardiovascular Medicine of the 1st Faculty of Medicine and General University Hospital Prague U Nemocnice 2 12800 Prague Czech Republic

Cardiology Department Institute of Clinical and Experimental Medicine Prague Czech Republic

Zobrazit více v PubMed

Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki Aet al. . 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67–119. PubMed

Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka Met al. . Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019;53:1801913. PubMed PMC

Wen L, Sun ML, An P, Jiang X, Sun K, Zheng Let al. . Frequency of supraventricular arrhythmias in patients with idiopathic pulmonary arterial hypertension. Am J Cardiol 2014;114:1420–5. PubMed

Olsson KM, Nickel NP, Tongers J, Hoeper MM. Atrial flutter and fibrillation in patients with pulmonary hypertension. Int J Cardiol 2013;167:2300–5. PubMed

Ruiz-Cano MJ, Gonzalez-Mansilla A, Escribano P, Delgado J, Arribas F, Torres Jet al. . Clinical implications of supraventricular arrhythmias in patients with severe pulmonary arterial hypertension. Int J Cardiol 2011;146:105–6. PubMed

Tongers J, Schwerdtfeger B, Klein G, Kempf T, Schaefer A, Knapp JMet al. . Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007;153:127–32. PubMed

Fingrova Z, Ambroz D, Jansa P, Kuchar J, Lindner J, Kunstyr Jet al. . The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension. PLoS One 2021;16:e0245752. PubMed PMC

Havranek S, Fingrova Z, Ambroz D, Jansa P, Kuchar J, Dusik Met al. . Atrial fibrillation and atrial tachycardia in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy. Eur Heart J Suppl 2020;22:F30–F7. PubMed PMC

Smith B, Genuardi MV, Koczo A, Zou RH, Thoma FW, Handen Aet al. . Atrial arrhythmias are associated with increased mortality in pulmonary arterial hypertension. Pulm Circ 2018;8:1–9. PubMed PMC

Showkathali R, Tayebjee MH, Grapsa J, Alzetani M, Nihoyannopoulos P, Howard LSet al. . Right atrial flutter isthmus ablation is feasible and results in acute clinical improvement in patients with persistent atrial flutter and severe pulmonary arterial hypertension. Int J Cardiol 2011;149:279–80. PubMed

Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone trials meta-analysis investigators. Lancet 1997;350:1417–24. PubMed

Soon E, Toshner M, Mela M, Grace A, Sheares K, Morrell Net al. . Risk of potentially life-threatening thyroid dysfunction due to amiodarone in idiopathic pulmonary arterial hypertension patients. J Am Coll Cardiol 2011;57:997–8. PubMed

Bradfield J, Shapiro S, Finch W, Tung R, Boyle NG, Buch Eet al. . Catheter ablation of typical atrial flutter in severe pulmonary hypertension. J Cardiovasc Electrophysiol 2012;23:1185–90. PubMed

Kamada H, Kaneyama J, Inoue YY, Noda T, Ueda N, Nakajima Ket al. . Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia. Sci Rep 2021;11:16176. PubMed PMC

Luesebrink U, Fischer D, Gezgin F, Duncker D, Koenig T, Oswald Het al. . Ablation of typical right atrial flutter in patients with pulmonary hypertension. Heart Lung Circ 2012;21:695–9. PubMed

Zhou B, Zhu YJ, Zhai ZQ, Weng SX, Ma YZ, Yu FYet al. . Radiofrequency catheter ablation of supraventricular tachycardia in patients with pulmonary hypertension: feasibility and long-term outcome. Front Physiol 2021;12:674909. PubMed PMC

Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga Let al. . 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Heart Rhythm 2017;14:e445–e94. PubMed

Voskoboinik A, Moskovitch JT, Harel N, Sanders P, Kistler PM, Kalman JM. Revisiting pulmonary vein isolation alone for persistent atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 2017;14:661–7. PubMed

Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan Ret al. . Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 2015;372:1812–22. PubMed

Zhou L, He L, Wang W, Li C, Li S, Tang Ret al. . Effect of repeat catheter ablation vs. antiarrhythmic drug therapy among patients with recurrent atrial tachycardia/atrial fibrillation after atrial fibrillation catheter ablation: data from CHINA-AF registry. Europace 2023;25:382–9. PubMed PMC

Medi C, Kalman JM, Ling LH, Teh AW, Lee G, Lee Get al. . Atrial electrical and structural remodeling associated with longstanding pulmonary hypertension and right ventricular hypertrophy in humans. J Cardiovasc Electr 2012;23:614–20. PubMed

Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IMet al. . Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43:S25–32. PubMed

Lai Y, Guo Q, Sang C, Gao M, Huang L, Zuo Set al. . Revisiting the characteristics and ablation strategy of biatrial tachycardias: a case series and systematic review. Europace 2023;25:905–13. PubMed PMC

Folino AF, Bobbo F, Schiraldi C, Tona F, Romano S, Buja Get al. . Ventricular arrhythmias and autonomic profile in patients with primary pulmonary hypertension. Lung 2003;181:321–8. PubMed

Schrier RW, Bansal S. Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol 2008;3:1232–7. PubMed PMC

Di Biase L, Conti S, Mohanty P, Bai R, Sanchez J, Walton Det al. . General anesthesia reduces the prevalence of pulmonary vein reconnection during repeat ablation when compared with conscious sedation: results from a randomized study. Heart Rhythm 2011;8:368–72. PubMed

Bellotti A, Arora S, Gustafson C, Funk I, Grossheusch C, Simmers Cet al. . Predictors of post-induction hypotension for patients with pulmonary hypertension. Cureus 2022;14:e31887. PubMed PMC

Lai HC, Lai HC, Wang KY, Lee WL, Ting CT, Liu TJ. Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery. Br J Anaesth 2007;99:184–90. PubMed

Witt CM, Fenstad ER, Cha YM, Kane GC, Kushwaha SS, Hodge DOet al. . Increase in pulmonary arterial pressure after atrial fibrillation ablation: incidence and associated findings. J Interv Card Electrophysiol 2014;40:47–52. PubMed

Yang Y, Liu Q, Wu Z, Li X, Xiao Y, Tu Tet al. . Stiff left atrial syndrome: A complication undergoing radiofrequency catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2016;27:884–9. PubMed

Zobrazit více v PubMed

ClinicalTrials.gov
NCT04053361